Target intelligence / Profile preview

Growth factor receptor-bound protein 7 (GRB7)

Target
GRB7
Molecular classification
Adaptor protein, SH2 domain-containing protein, Pleckstrin homology domain-containing protein, Signal transduction protein
01

Overview

Growth factor receptor-bound protein 7 (GRB7) is an adaptor protein that contains Src homology 2 (SH2) and pleckstrin homology (PH) domains, enabling it to interact with receptor tyrosine kinases such as EGFR and ERBB2 (HER2), as well as focal adhesion kinase (FAK). GRB7 modulates key intracellular signaling pathways linked to cell migration, proliferation, and integrin signaling, with prominent roles in cancer cell invasion and metastasis. The GRB7 gene is frequently co-amplified with ERBB2 in multiple cancers and its overexpression is associated with poor patient prognosis, making it both a candidate prognostic biomarker and a potential therapeutic target, particularly in HER2-positive tumors. Experimental peptide inhibitors targeting the SH2 domain have shown preclinical anti-cancer activity by disrupting its protein-protein interactions, although no approved GRB7-specific drugs are available.

Other names
GRB7B47Epidermal growth factor receptor GRB-7GRB7 adapter proteingrowth factor receptor bound protein 7
02

Mechanism of action

Inhibition of GRB7 SH2 domain interaction with phosphorylated receptor tyrosine kinases (e.g., EGFR, ERBB2) to block downstream signaling and migration; suppression of integrin or focal adhesion signaling to reduce tumor cell invasiveness

03

Biological functions

Signal transductionCell migrationCell proliferationIntegrin signalingFocal adhesion dynamicsRegulation of receptor tyrosine kinase signaling
04

Disease associations

Cancer (breast cancer, gastric cancer, esophageal cancer, testicular germ cell tumor, ovarian cancer)Tumor progressionMetastasis
05

Safety considerations

Targeting adaptor proteins may have broad effects on cell signalingPossible off-target consequences in normal tissue biology, given GRB7 expression in diverse tissuesRisk of impairing wound healing or normal cell migration
06

Interacting drugs

Peptide inhibitors of GRB7 SH2 domain

1 more in the full profile.

07

Biomarkers

High GRB7 expression as a poor prognostic marker in HER2-positive and other cancersCo-amplification with ERBB2 is a marker of more aggressive tumor biology

Beyond the preview

Go deeper on Growth factor receptor-bound protein 7 (GRB7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth factor receptor-bound protein 7 (GRB7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call